These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31366808)

  • 1. Author's Reply: Why Did the Patient Not Show Any Neurological Symptoms on the Day of the Higher Serum Concentration of Ceftriaxone?
    Suzuki S; Naito S; Uchida S
    Intern Med; 2019 Dec; 58(24):3617. PubMed ID: 31366808
    [No Abstract]   [Full Text] [Related]  

  • 2. Why Did the Patient Not Show Any Neurological Symptoms on the Day of the Higher Serum Concentration of Ceftriaxone?
    Fukuchi T; Sugawara H
    Intern Med; 2019 Dec; 58(24):3615. PubMed ID: 31366806
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid.
    Nishioka H; Cho Y; Irie K; Kanamori M
    Int J Infect Dis; 2022 Mar; 116():223-225. PubMed ID: 35063677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentrations in a Hemodialysis Patient.
    Suzuki S; Naito S; Numasawa Y; Asada M; Shoji N; Zeniya M; Takahashi D; Sato H; Iimori S; Nomura N; Sohara E; Okado T; Ishiwata Y; Nagata M; Rai T; Yokota T; Uchida S
    Intern Med; 2019 Jun; 58(12):1775-1779. PubMed ID: 30799339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations.
    Allegra S; Cardellino CS; Fatiguso G; Cusato J; De Nicolò A; Avataneo V; Bonora S; D'Avolio A; Di Perri G; Calcagno A
    J Clin Pharmacol; 2018 Dec; 58(12):1550-1556. PubMed ID: 29873816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone effect on bilirubin-albumin binding.
    Fink S; Karp W; Robertson A
    Pediatrics; 1987 Dec; 80(6):873-5. PubMed ID: 3684399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone binding to human serum albumin: competition with bilirubin.
    Brodersen R; Robertson A
    Mol Pharmacol; 1989 Sep; 36(3):478-83. PubMed ID: 2779527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro study of ceftriaxone binding to blood].
    Brandebourger M; Barré J; Hamberger C; Pochet I; Tillement JP
    Pathol Biol (Paris); 1986 May; 34(5):320-4. PubMed ID: 3534698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of ceftriaxone concentration in human cerebrospinal fluid by high-performance liquid chromatography with UV detection.
    Kotani A; Hirai J; Hamada Y; Fujita J; Hakamata H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():161-164. PubMed ID: 31202181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The penetration of ceftriaxone into synovial fluid of the inflamed joint.
    Morgan JR; Paull A; O'Sullivan M; Williams BD
    J Antimicrob Chemother; 1985 Sep; 16(3):367-71. PubMed ID: 4055544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone-induced Neurotoxicity in a Patient after Pancreas-Kidney Transplantation.
    Hagiya H; Miyawaki K; Yamamoto N; Yoshida H; Kitagawa A; Asaoka T; Eguchi H; Akeda Y; Tomono K
    Intern Med; 2017 Nov; 56(22):3103-3107. PubMed ID: 28943562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs in liver disease and during albumin dialysis -MARS.
    Majcher-Peszynska J; Peszynski P; Müller SC; Klammt S; Wacke R; Mitzner S; Stange J; Mundkowski R; Hehl EM; Schmidt R; Drewelow B
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():33-5. PubMed ID: 16215894
    [No Abstract]   [Full Text] [Related]  

  • 13. Protein binding of ceftriaxone in extravascular fluids.
    McNamara PJ; Trueb V; Stoeckel K
    J Pharm Sci; 1988 May; 77(5):401-4. PubMed ID: 3411461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasminogen concentration in the cerebrospinal fluid of patients with various neurological diseases (author's transl)].
    Maruyama I; Igata A
    Rinsho Shinkeigaku; 1979 Aug; 19(8):481-5. PubMed ID: 498662
    [No Abstract]   [Full Text] [Related]  

  • 15. [The natural history of dialysis encephalopathy (author's transl)].
    Pogglitsch H; Wawschinek O; Holzer H; Petek W; Ladurner G; Katschnig H; Korthals C
    Acta Med Austriaca; 1980; 7(3):71-6. PubMed ID: 7223340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Albumin and IGG in the CSF as demonstration of blood-brain barrier damage and of immune response within the CNS (author's transl)].
    Cognazzo A; Gerbino Promis PC; Grasso E
    Riv Patol Nerv Ment; 1981; 101(3):151-64. PubMed ID: 7256113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic determination of the binding of ceftriaxone to human serum albumin solution and albumin from diluted human serum.
    Mohler J; Meulemans A; Vulpillat M
    J Chromatogr; 1990 Jun; 528(2):415-23. PubMed ID: 2384579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pattern of cerebrospinal fluid proteins in infants and children. Determination of normal values (author's transl)].
    Gerbaut L; Ponsot G; Dulac O; Olive G; Arthuis M
    Arch Fr Pediatr; 1981 Jan; 38(1):3-9. PubMed ID: 7224799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Penetration of ceftriaxone into the cerebrospinal fluid and its relationship to inflammatory markers during bacterial meningitis].
    Prásil P; Buchta V; Paterová P; Hanovcová I
    Klin Mikrobiol Infekc Lek; 2010 Apr; 16(2):64-72. PubMed ID: 20503158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting ceftriaxone plasma protein binding during open heart surgery.
    Jungbluth GL; Pasko MT; Jusko WJ
    J Pharm Sci; 1989 Oct; 78(10):807-11. PubMed ID: 2600784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.